<narrative>Continued scale-up of diagnostic and treatment services for HIV and TB, at health facility and community levels - Burundi (01-Jan-2018-31-Dec-2020)</narrative>

47045-BDI-C-UNDP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Continued scale-up of diagnostic and treatment services for HIV and TB, at health facility and community levels - Burundi (01-Jan-2018-31-Dec-2020)</narrative> Burundi, TB/HIV, United Nations Development Programme Goals: Contribuer à l’amélioration de la santé de la population burundaise en réduisant le fardeau lié à la tuberculose; Les nouvelles infections à VIH sont réduites de 19% de 2018 à 2022; La mortalité liée au VIH et au SIDA est réduite de 34% de 2018 à 2022. Objectives: Augmenter la détection précoce de 7662 cas à 9313 cas de TB TTF dans la population générale y compris les groupes à hauts risques (PVVIH, Réfugiés, prisonniers, enfants) soit une augmentation de 18% de 2016 à 2020; Augmenter le dépistage des cas TB/MR en passant de 80 en 2016 à 165 cas TB/MR attendus selon l’estimation OMS soit une augmentation de 85 cas de 2016 à 2020; Maintenir le taux de succès thérapeutique des nouveaux patients bactériologique ment confirmés et des cas TB/MR à plus de 90%; Améliorer la prévention de la tuberculose (contrôle de l’infection dans les établissements de soins, le changement de comportement dans la population générale et la prévention par des médicaments), de sorte que le pourcentage de la population ayant une connaissance adéquate de la tuberculose passe de 76% à 90% en 2020; Améliorer les capacités de gestion du programme de lutte antituberculeuse: améliorer la surveillance, le système de suivi/évaluation et de recherche opérationnelle; La couverture des soins ARV de qualité est augmentée de 60%(2018) à 85%(2022) chez les enfants de 0 à 14 ans et de 75% (2018) à 95%(2022) chez les adultes; % de PVVIH (d'adultes et d'enfants) qui ont commencé la therapie antiretrovirale qui ont une une charge virale indectable à 12 mois (inferieure à 1000 copies /ml ) est augmentée de 86 % à 89%; La prévention à l’INH chez 95% des PVVIH screennées TB négative et le traitement de la TB sont assurés chez 95 % des PVVIH coïnfectés par la TB; La couverture en ARV pour la PTME passe de 95% (2018) à 99% (2022) pour les femmes et de 95% (2018) à 99% (2022) pour les nouveau nés des femmes séropositives.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Gilles Cesari

Fund Portfolio Manager

+41 58 791 1700 gilles.cesari@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Burundi

HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage

HIV -> Comprehensive prevention programs for MSM -> Behavioral interventions for MSM

HIV -> Comprehensive prevention programs for MSM -> Condoms and lubricant programming for MSM

HIV -> Comprehensive prevention programs for MSM -> Other intervention(s) for MSM

HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Behavioral interventions for PWID

HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Condoms and lubricant programming for PWID

HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Other intervention(s) for IDUs and their partners

HIV -> Comprehensive prevention programs for sex workers and their clients -> Behavioral interventions for sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> Condoms and lubricant programming for sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> HIV testing services for sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> Other intervention(s) for sex workers and their clients

HIV -> Comprehensive programs for people in prisons and other closed settings -> Condoms and lubricant programming for people in prisons and other closed settings

HIV -> Differentiated HIV Testing Services -> Differentiated HIV testing services

HIV -> PMTCT -> Other intervention(s) for PMTCT

HIV -> PMTCT -> Prong 1: Primary prevention of HIV infection among women of childbearing age

HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission

HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families

HIV -> Prevention programs for adolescents and youth, in and out of school -> Male and Female condoms for adolescents and youth, in and out of school

HIV -> Prevention programs for general population -> Behavioral interventions as part of programs for general population

HIV -> Prevention programs for general population -> Gender-based violence prevention and treatment programs for general population

HIV -> Prevention programs for general population -> Other intervention(s) for general population

HIV -> Prevention programs for other vulnerable populations -> HIV testing services for other vulnerable populations

HIV -> Prevention programs for other vulnerable populations -> Male and female condoms for other vulnerable populations

HIV -> Treatment, care and support -> Counseling and psycho-social support

HIV -> Treatment, care and support -> Differentiated ART service delivery

HIV -> Treatment, care and support -> HIV care

HIV -> Treatment, care and support -> Other intervention(s) for treatment

HIV -> Treatment, care and support -> Prevention, diagnosis and treatment of opportunistic infections

HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance

HIV -> Treatment, care and support -> Treatment monitoring - Viral load

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency

RSSH -> RSSH: Health management information systems and M&E -> Program and data quality

RSSH -> RSSH: Health management information systems and M&E -> Routine reporting

RSSH -> RSSH: Health management information systems and M&E -> Surveys

RSSH -> RSSH: Integrated service delivery and quality improvement -> Laboratory systems for disease prevention, control, treatment and disease surveillance

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners

Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention)

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

6103880.88

11163212.83

18377710.48

17644578.38 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4298066.74 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1843806.00 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1327218.58 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BDI-C-UNDPP01 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

5988756.53 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4164623.49 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

14678749.06 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-22107.04 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4852778.00 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BDI-C-UNDPP01 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3014477.82 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4483586.00 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3752728.14 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-2327907.24 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2778508.60 Global Fund disbursement to BDI-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

6695.28 Funds returned to the Global Fund from BDI-C-UNDPP01 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-6695.28 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BDI-C-UNDPP01 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

22431.00 Funds returned to the Global Fund from BDI-C-UNDPP01 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-22431.00 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3018.01 Funds returned to the Global Fund from BDI-C-UNDPP01 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-3018.01 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-974219.54 Global Fund commitment to BDI-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

6283006.00 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP01, Jan 2018 to Dec 2018.

United Nations Development Programme

11135468.95 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP01, Jan 2019 to Dec 2019.

United Nations Development Programme

14777331.26 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP01, Jan 2020 to Dec 2020.

United Nations Development Programme

-401152.88 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP01, Jan 2021 to Jun 2021.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1833; Denominator: 10035.

Numerator: 4156.5; Denominator: 10522. Numerator: 4351; Denominator: 10522.

Numerator: 8313; Denominator: 10522. Numerator: 10280; Denominator: 10522.

Numerator: 4364; Denominator: 10775. Numerator: 7494; Denominator: 10775.

Numerator: 8728; Denominator: 10755. Numerator: 14801; Denominator: 10755.

Numerator: 4579; Denominator: 11034. Numerator: 9047; Denominator: 11034.

Numerator: 9158; Denominator: 11034. Numerator: 15628; Denominator: 11034.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 975; Denominator: 10035.

Numerator: 3524.87; Denominator: 10522. Numerator: 2594; Denominator: 10522.

Numerator: 7049.74; Denominator: 10522. Numerator: 6321; Denominator: 10522.

Numerator: 3656.7; Denominator: 10775. Numerator: 3296; Denominator: 10775.

Numerator: 7313.4; Denominator: 10755. Numerator: 6591; Denominator: 10755.

Numerator: 3806.73; Denominator: 11034. Numerator: 4615; Denominator: 11034.

Numerator: 7613.46; Denominator: 11034. Numerator: 8805; Denominator: 11034.

<narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 14364; Denominator: 55278.

Numerator: 24054.5; Denominator: 57963. Numerator: 26604; Denominator: 57963.

Numerator: 48109; Denominator: 57963. Numerator: 49420; Denominator: 57963.

Numerator: 25225.5; Denominator: 59354. Numerator: 23733; Denominator: 59354.

Numerator: 50451; Denominator: 59354. Numerator: 49989; Denominator: 59354.

Numerator: 26439; Denominator: 60779. Numerator: 29882; Denominator: 60779.

Numerator: 52878; Denominator: 60779. Numerator: 59545; Denominator: 60779.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 6393; Denominator: 55278.

Numerator: 20287.05; Denominator: 57963. Numerator: 16484; Denominator: 57963.

Numerator: 40574.1; Denominator: 57963. Numerator: 29967; Denominator: 57963.

Numerator: 21070.67; Denominator: 59354. Numerator: 16835; Denominator: 59354.

Numerator: 42141.34; Denominator: 59354. Numerator: 37590; Denominator: 59354.

Numerator: 21880.44; Denominator: 60779. Numerator: 20760; Denominator: 60779.

Numerator: 43760.88; Denominator: 60779. Numerator: 39410; Denominator: 60779.

<narrative>Number of people who were tested for HIV and received their results during the reporting period</narrative> Module: Differentiated HIV Testing Services. <narrative>Number of people who were tested for HIV and received their results during the reporting period</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1513254; Denominator: 1528625; Percentage: 0.99%. Numerator: 1513254; Denominator: 1528625; Percentage: 0.99%. Numerator: 15371; Denominator: 1528625; Percentage: 0.01%. Numerator: 15371; Denominator: 1528625; Percentage: 0.01%. Numerator: 704199.

Numerator: 537675. Numerator: 938645.

Numerator: 1075350. Numerator: 2008439. Numerator: 1740467. Numerator: 13850.

Numerator: 548863.5. Numerator: 567110.

Numerator: 1097727. Numerator: 982024. Numerator: 1000834. Numerator: 16403.

Numerator: 560476. Numerator: 408173.

Numerator: 1120952. Numerator: 842311.

<narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 80. Numerator: 78. Numerator: 78. Numerator: 78. Numerator: 78. Numerator: 2. Numerator: 2. Numerator: 2. Numerator: 2. Numerator: 27. Numerator: 27. Numerator: 27. Numerator: 27. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 53.

Numerator: 73.5. Numerator: 20; Percentage: 27%.

Numerator: 73.5. Numerator: 30. Numerator: 30. Numerator: 0. Numerator: 7. Numerator: 23.

Numerator: 78.5. Numerator: 29.

Numerator: 78.5. Numerator: 35. Numerator: 34. Numerator: 1. Numerator: 8. Numerator: 27.

Numerator: 82.5. Numerator: 32. Numerator: 32; Denominator: 32; Percentage: 100%. Numerator: 0; Denominator: 32; Percentage: 0%. Numerator: 11; Denominator: 32; Percentage: 34.4%. Numerator: 21; Denominator: 32; Percentage: 65.6%.

Numerator: 82.5. Numerator: 30. Numerator: 29. Numerator: 1. Numerator: 9. Numerator: 21.

<narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 80. Numerator: 78. Numerator: 78. Numerator: 78. Numerator: 78. Numerator: 2. Numerator: 2. Numerator: 2. Numerator: 2. Numerator: 27. Numerator: 27. Numerator: 27. Numerator: 27. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 80. Numerator: 80. Numerator: 80. Numerator: 80.

Numerator: 73.5. Numerator: 20; Denominator: 20; Percentage: 100%.

Numerator: 73.5. Numerator: 30; Denominator: 30; Percentage: 100%. Numerator: 30. Numerator: 0. Numerator: 7. Numerator: 23. Numerator: 0. Numerator: 30.

Numerator: 78.5. Numerator: 29; Denominator: 29; Percentage: 100%.

Numerator: 78.5. Numerator: 35. Numerator: 34. Numerator: 1. Numerator: 8. Numerator: 27. Numerator: 0. Numerator: 35.

Numerator: 82.5. Numerator: 32. Numerator: 32. Numerator: 0. Numerator: 11. Numerator: 21. Numerator: 0. Numerator: 32.

Numerator: 82.5. Numerator: 30. Numerator: 29. Numerator: 1. Numerator: 9. Numerator: 21. Numerator: 0. Numerator: 30.

Numerator: 2021; Denominator: 2806.5. Numerator: 506; Denominator: 2806.

Numerator: 4042; Denominator: 5613. Numerator: 2207; Denominator: 5613.

Numerator: 2164; Denominator: 2885.5. Numerator: 1813; Denominator: 2886.

Numerator: 4328; Denominator: 5771. Numerator: 3495; Denominator: 33242.

Numerator: 2373; Denominator: 2966. Numerator: 913; Denominator: 2966.

Numerator: 4746; Denominator: 5932. Numerator: 2312; Denominator: 5932.

<narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 2215; Denominator: 2600.

Numerator: 2666.18; Denominator: 2806.5. Numerator: 2110; Denominator: 2807.

Numerator: 5332.35; Denominator: 5613. Numerator: 3986; Denominator: 5000.

Numerator: 2770.08; Denominator: 2885.5. Numerator: 3297; Denominator: 2886.

Numerator: 5540.16; Denominator: 5771. Numerator: 6472; Denominator: 5771.

Numerator: 2877.02; Denominator: 2966. Numerator: 2657; Denominator: 2966.

Numerator: 5754.04; Denominator: 5932. Numerator: 4140; Denominator: 5932.

Numerator: 213843.2; Denominator: 267304. Numerator: 193020; Denominator: 267304.

Numerator: 427686.4; Denominator: 534608. Numerator: 421858; Denominator: 534608.

Numerator: 247309.65; Denominator: 274788.5. Numerator: 200947; Denominator: 274788.

Numerator: 494619.3; Denominator: 549577. Numerator: 418249; Denominator: 602208.

Numerator: 268358.38; Denominator: 282482.5. Numerator: 191055; Denominator: 282482.

Numerator: 536716.75; Denominator: 564965. Numerator: 402436; Denominator: 564965.

<narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 170; Denominator: 170.

Numerator: 170; Denominator: 170. Numerator: 170; Denominator: 170.

Numerator: 170; Denominator: 170. Numerator: 170; Denominator: 172.

Numerator: 170; Denominator: 170. Numerator: 173; Denominator: 173.

<narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Module: TB care and prevention. <narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative.

<narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Geographic coverage: National. Aggregation: Non cumulative.

<narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 7662. Numerator: 7270. Numerator: 7270. Numerator: 7270. Numerator: 7270. Numerator: 392. Numerator: 392. Numerator: 392. Numerator: 392. Numerator: 4585. Numerator: 4585. Numerator: 4585. Numerator: 4585. Numerator: 2740. Numerator: 2740. Numerator: 2740. Numerator: 2740. Numerator: 4922. Numerator: 4922. Numerator: 4922. Numerator: 4922. Numerator: 6468. Numerator: 6468. Numerator: 6468. Numerator: 6468. Numerator: 317. Numerator: 317. Numerator: 317. Numerator: 317. Numerator: 877. Numerator: 877. Numerator: 877. Numerator: 877.

Numerator: 4223.5. Numerator: 3827.

Numerator: 4223.5. Numerator: 3375. Numerator: 3187. Numerator: 188. Numerator: 2109. Numerator: 1166. Numerator: 2209. Numerator: 2988. Numerator: 44. Numerator: 343.

Numerator: 4435. Numerator: 3468.

Numerator: 4435. Numerator: 3359. Numerator: 3213; Denominator: 3359; Percentage: 95.7%. Numerator: 146; Denominator: 3359; Percentage: 4.3%. Numerator: 2136; Denominator: 3359; Percentage: 63.6%. Numerator: 1141; Denominator: 3359; Percentage: 34%. Numerator: 2218; Denominator: 3359; Percentage: 66%. Numerator: 3063; Denominator: 3325; Percentage: 92.1%. Numerator: 34; Denominator: 3359; Percentage: 1%. Numerator: 262; Denominator: 3325; Percentage: 7.9%.

Numerator: 4656.5. Numerator: 3646. Numerator: 3478; Denominator: 3646; Percentage: 95.4%. Numerator: 168; Denominator: 3646; Percentage: 4.6%. Numerator: 2260; Denominator: 3646; Percentage: 62%. Numerator: 1168; Denominator: 3646; Percentage: 32%. Numerator: 2478; Denominator: 3646; Percentage: 68%. Numerator: 3330; Denominator: 3646; Percentage: 91.3%. Numerator: 8; Denominator: 3646; Percentage: 0.2%. Numerator: 308; Denominator: 3646; Percentage: 8.4%.

Numerator: 4656.5. Numerator: 3569. Numerator: 3448; Denominator: 3569; Percentage: 96.6%. Numerator: 121; Denominator: 3569; Percentage: 3.4%. Numerator: 2350; Denominator: 3569; Percentage: 65.8%. Numerator: 1132; Denominator: 3569; Percentage: 31.7%. Numerator: 2437; Denominator: 3569; Percentage: 68.3%. Numerator: 3294; Denominator: 3569; Percentage: 92.3%. Numerator: 24; Denominator: 3569; Percentage: 0.7%. Numerator: 251; Denominator: 3569; Percentage: 7%.

<narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 169; Denominator: 171.

Numerator: 171; Denominator: 171. Numerator: 0; Denominator: 171.

Numerator: 171; Denominator: 171. Numerator: 165; Denominator: 168.

Numerator: 171; Denominator: 171. Numerator: 0; Denominator: 171.

Numerator: 171; Denominator: 171. Numerator: 165; Denominator: 173.

Numerator: 171; Denominator: 171. Numerator: 156; Denominator: 172.

Numerator: 171; Denominator: 171. Numerator: 164; Denominator: 173.

<narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Module: TB care and prevention. <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 170; Denominator: 170.

Numerator: 170; Denominator: 170. Numerator: 167; Denominator: 170.

Numerator: 170; Denominator: 170. Numerator: 170; Denominator: 170.

Numerator: 170; Denominator: 170. Numerator: 170; Denominator: 172.

Numerator: 170; Denominator: 170. Numerator: 174; Denominator: 174.

Numerator: 170; Denominator: 170. Numerator: 173; Denominator: 173.

Numerator: 3712.77; Denominator: 4022.5. Numerator: 2342; Denominator: 2484.

Numerator: 3712.77; Denominator: 4022.5. Numerator: 2150; Denominator: 2275. Numerator: 628; Denominator: 2150.

Numerator: 3898.29; Denominator: 4223.5. Numerator: 2030; Denominator: 2144.

Numerator: 3898.29; Denominator: 4223.5. Numerator: 3152; Denominator: 3375. Numerator: 1067; Denominator: 3152.

Numerator: 4093.51; Denominator: 4435. Numerator: 3250; Denominator: 3468. Numerator: 1117; Denominator: 1181.

Numerator: 4093.51; Denominator: 4435. Numerator: 3155; Denominator: 3360. Numerator: 1096; Denominator: 1141.

<narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 795; Denominator: 877.

Numerator: 661.92; Denominator: 689.5. Numerator: 406; Denominator: 410.

Numerator: 661.92; Denominator: 689.5. Numerator: 337; Denominator: 343.

Numerator: 695.04; Denominator: 724. Numerator: 304; Denominator: 307.

Numerator: 695.04; Denominator: 724. Numerator: 262; Denominator: 262.

Numerator: 681.6; Denominator: 710. Numerator: 307; Denominator: 308.

Numerator: 681.6; Denominator: 710. Numerator: 250; Denominator: 251.

<narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 27472; Denominator: 61538.

Numerator: 38211; Denominator: 63685. Numerator: 27509; Denominator: 62281.

Numerator: 38211; Denominator: 63685. Numerator: 28779.5; Denominator: 62094.

Numerator: 44579.5; Denominator: 63685. Numerator: 31334; Denominator: 61849.

Numerator: 44579.5; Denominator: 63685. Numerator: 31564; Denominator: 66344.

Numerator: 50948; Denominator: 63685. Numerator: 32100; Denominator: 71098.

Numerator: 50948; Denominator: 63685. Numerator: 24859.33; Denominator: 73005.

<narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 198; Denominator: 6166.

Numerator: 646.1; Denominator: 1846. Numerator: 184; Denominator: 3013.

Numerator: 646.1; Denominator: 1846. Numerator: 1257; Denominator: 1947.

Numerator: 692.25; Denominator: 1846. Numerator: 1542; Denominator: 10071.

Numerator: 692.25; Denominator: 1846. Numerator: 1808; Denominator: 9323.

Numerator: 738.4; Denominator: 1846. Numerator: 1926; Denominator: 8100.

Numerator: 738.4; Denominator: 1846. Numerator: 3091; Denominator: 5585.

<narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 7345; Denominator: 7662.

Numerator: 4054.56; Denominator: 4223.5. Numerator: 3727; Denominator: 3827.

Numerator: 4054.56; Denominator: 4223.5. Numerator: 3331; Denominator: 3375.

Numerator: 4257.6; Denominator: 4435. Numerator: 3293; Denominator: 3468.

Numerator: 4257.6; Denominator: 4435. Numerator: 3325; Denominator: 3359.

Numerator: 4470.24; Denominator: 4656.5. Numerator: 3638; Denominator: 3646.

Numerator: 4470.24; Denominator: 4656.5. Numerator: 3545; Denominator: 3569.

<narrative>Percentage of ART sites that had a stock-out of any antiretroviral drugs during the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of ART sites that had a stock-out of any antiretroviral drugs during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 211; Denominator: 678.

Numerator: 33.9; Denominator: 678. Numerator: 174; Denominator: 717.

Numerator: 33.9; Denominator: 678. Numerator: 29; Denominator: 760.

Numerator: 33.9; Denominator: 678. Numerator: 60; Denominator: 828.

Numerator: 33.9; Denominator: 678. Numerator: 95; Denominator: 846.

Numerator: 33.9; Denominator: 678. Numerator: 74; Denominator: 868.

Numerator: 33.9; Denominator: 678. Numerator: 84; Denominator: 885.

<narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 48867; Denominator: 75204. Numerator: 48867; Denominator: 75204. Numerator: 48867; Denominator: 75204. Numerator: 48867; Denominator: 75204. Numerator: 3050; Denominator: 8238. Numerator: 3050; Denominator: 8238. Numerator: 3050; Denominator: 8238. Numerator: 3050; Denominator: 8238. Numerator: 57121; Denominator: 82664.

Numerator: 60685; Denominator: 82045. Numerator: 61296; Denominator: 82045.

Numerator: 60685; Denominator: 82045. Numerator: 62093.9; Denominator: 82045. Numerator: 58893.35; Denominator: 62093. Numerator: 3200.55; Denominator: 62093.

Numerator: 60685; Denominator: 81533. Numerator: 61849; Denominator: 81533.

Numerator: 60685; Denominator: 81533. Numerator: 66344; Denominator: 81533. Numerator: 63223; Denominator: 66344. Numerator: 3121; Denominator: 66344.

Numerator: 60685; Denominator: 81017. Numerator: 71098; Denominator: 81017. Numerator: 67984; Denominator: 71098. Numerator: 3114; Denominator: 71098.

Numerator: 60685; Denominator: 81017. Numerator: 73033; Denominator: 81017. Numerator: 69991; Denominator: 73033. Numerator: 3042; Denominator: 73033.

47045-BDI-C-UNDP-2

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>PACTE-TB/VIH : Programme d’Accélération vers le Contrôle de la Transmission de l’Epidémie du VIH et de la Tuberculose au Burundi - Burundi (01-Jan-2021-31-Dec-2023)</narrative> Burundi, TB/HIV, United Nations Development Programme Goals: Intensifier la prévention des nouvelles infections par voie sexuelle et sanguine chez les adolescents et jeunes et parmi les populations clés Intensify prevention of new sexual and blood-borne infections among adolescents and young people and key populations; Renforcer la prévention de la transmission du VIH de la mère à l’enfant, la prise en charge pédiatrique précoce et le maintien de leurs mères en vie. Strengthen prevention of mother-to-child transmission of HIV, early paediatric care and keeping mothers alive; Baisser la mortalité liée au VIH/sida Reduce HIV/AIDS-related mortality; Atténuer l’impact et les déterminants de la vulnérabilité liée au VIH sur les populations vulnérables Mitigating the impact and determinants of HIV-related vulnerability on vulnerable populations; Renforcer et améliorer la gestion et coordination de la réponse nationale dans l’esprit des « Three ones » Strengthen and improve the management and coordination of the national response in the spirit of the Three Ones ; Mettre fin à la tendance épidémique de la tuberculose au Burundi afin de libérer la population du fardeau lié à la TB et ses comorbidités pour sa participation au développement du pays. To put an end to the epidemic trend of tuberculosis in Burundi in order to free the population from the burden of TB and its co-morbidities for its participation in the development of the country. Objectives: Le nombre de nouvelles infections à VIH est réduit de 20% dans la population générale et dans les groupes les plus exposés au risque VIH de 2018 à 2022 The number of new HIV infections is reduced by 20% in the general population and in most-at-risk groups between 2018 and 2022; Le risque de TME est réduit de 13.88% en 2017 à 2% en 2022 MCT risk is reduced from 13.88% in 2017 to 2% in 2022; La mortalité liée au VIH et au SIDA est réduite de 34% de 2018 à 2022 HIV and AIDS mortality is reduced by 34% from 2018 to 2022; Les conditions de vie d'au moins 80% des personnes infectées et affectées par le VIH et sida et démunies sont améliorées d’ici à 2022 The living conditions of at least 80% of people infected and affected by HIV and AIDS and the poor are improved by 2022; La gestion de la réponse nationale au VIH et au sida est efficace, efficiente et performante, dans le respect des « Three ones » The management of the national response to HIV and AIDS is effective, efficient and efficient, in line with the Three ones ; Assurer le dépistage et le diagnostic de 121,666 présumés de tuberculose y compris les enfants et autres groupes à risque attendus de 2021 à 2023, à raison de 8099 en 2021, de 8909 en 2022 et de 9800 en 2023. To screen and diagnose 121,666 suspected tuberculosis patients, including children and other at-risk groups expected from 2021 to 2023, at a rate of 8099 in 2021, 8909 in 2022, and 9800 in 2023 ; Dépister et traiter 636 patients TB/MR de 2021 à 2023 dont 166 en 2021, 211 en 2022 et 259 en 2023, soit une augmentation taux de 12,8% en 2018 à 61, 2% en 2023. Detect and treat 636 MDR/TB patients from 2021 to 2023, including 166 in 2021, 211 in 2022 and 259 in 2023, a rate increase from 12.8% in 2018 to 61.2% in 2023 ; Maintenir respectivement, le taux de succès thérapeutique à plus de 93% chez les nouveaux patients tuberculeux et à plus de 90% chez les nouveaux patients TB/MR, de 2021 à 2023. Maintain, respectively, a treatment success rate of more than 93% in new TB patients and more than 90% in new MDR/TB patients from 2021 to 2023; Tester au VIH 100% des tuberculeux et mettre sous traitement antirétroviral 100% des patients coinfectés TB/VIH, de 2021 à 2023. Test 100% of tuberculosis patients for HIV and putting 100% of TB/HIV co-infected patients on antiretroviral treatment, from 2021 to 2023; Améliorer les capacités de gestion du programme de lutte antituberculeuse: améliorer la surveillance, le système de suivi/évaluation et de recherche opérationnelle. Improve the management capacity of the tuberculosis control program: improve the surveillance, monitoring/evaluation and operational research system.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Gilles Cesari

Fund Portfolio Manager

+41 58 791 1700 gilles.cesari@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Burundi

HIV -> Differentiated HIV Testing Services -> Community-based testing

HIV -> Differentiated HIV Testing Services -> Facility-based testing

HIV -> Differentiated HIV Testing Services -> Self-testing

HIV -> PMTCT -> Prong 1: Primary prevention of HIV infection among women of childbearing age

HIV -> PMTCT -> Prong 2: Preventing unintended pregnancies among women living with HIV

HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission

HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families

HIV -> Prevention -> Behavior change interventions

HIV -> Prevention -> Community empowerment

HIV -> Prevention -> Condom and lubricant programming

HIV -> Prevention -> Pre-exposure prophylaxis

HIV -> Prevention -> Prevention and management of co-infections and co-morbidities (Prevention)

HIV -> Prevention -> Sexual and reproductive health services, including STIs

HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services

HIV -> Reducing human rights-related barriers to HIV/TB services -> Human rights and medical ethics related to HIV and HIV/TB for health care providers

HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights" campaign)

HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity

HIV -> Reducing human rights-related barriers to HIV/TB services -> Sensitization of law-makers and law-enforcement agents

HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB)

HIV -> Treatment, care and support -> Counseling and psycho-social support

HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care

HIV -> Treatment, care and support -> Orphan and vulnerable children package

HIV -> Treatment, care and support -> Prevention and management of co-infections and co-morbidities (Treatment, care and support)

HIV -> Treatment, care and support -> Treatment monitoring - ARV toxicity

HIV -> Treatment, care and support -> Treatment monitoring - Viral load

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Community systems strengthening -> Social mobilization, building community linkages and coordination

RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency

RSSH -> RSSH: Health management information systems and M&E -> Routine reporting

RSSH -> RSSH: Health management information systems and M&E -> Surveys

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Prevention (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention)

Tuberculosis -> TB care and prevention -> Key Populations (TB care and prevention) - Children

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners

Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention)

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> Collaborative activities with other programs and sectors (TB/HIV)

Tuberculosis -> TB/HIV -> Community TB/HIV care delivery

Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Prisoners

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

Tuberculosis -> TB/HIV -> TB/HIV - Prevention

Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis

Tuberculosis -> TB/HIV -> Treatment (TB/HIV)

7731670.37

12674813.20

24433978.48

26823062.87 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

9271601.79 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4713949.65 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1653756.90 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

9423548.45 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BDI-C-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1760206.08 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

15212806.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

13621946.00 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1590860.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1500000.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BDI-C-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4321.92 Funds returned to the Global Fund from BDI-C-UNDPP02 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-4321.92 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1257026.13 Global Fund disbursement to BDI-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

8180.80 Funds returned to the Global Fund from BDI-C-UNDPP02 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-8180.80 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-13230.08 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

13230.08 Funds returned to the Global Fund from BDI-C-UNDPP02 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-2013036.00 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2013036.00 Funds returned to the Global Fund from BDI-C-UNDPP02 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-242973.87 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4764.07 Funds returned to the Global Fund from BDI-C-UNDPP02 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-4764.07 Global Fund commitment to BDI-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

7731670.36 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP02, Jan 2021 to Dec 2021.

United Nations Development Programme

12669019.56 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP02, Jan 2022 to Dec 2022.

United Nations Development Programme

20167968.29 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP02, Jan 2023 to Dec 2023.

United Nations Development Programme

162759.47 Expenditure reported by United Nations Development Programme for BDI-C-UNDPP02, Jan 2024 to Jun 2024.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>2020 - Funding Request - Window 1 - TB/HIV - Burundi - English</narrative> Funding Request of funding request FR739-BDI-C.

<narrative>2020 - Funding Request - Window 1 - TB/HIV - Burundi - Français</narrative> Funding Request of funding request FR739-BDI-C.

<narrative>Percentage of HIV-positive results among the total HIV tests performed during the reporting period</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of HIV-positive results among the total HIV tests performed during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 16217; Denominator: 1036041; Percentage: 1.57%. Numerator: 734; Denominator: 64456; Percentage: 1.14%. Numerator: 734; Denominator: 64456; Percentage: 1.14%. Numerator: 734; Denominator: 64456; Percentage: 1.14%. Numerator: 15336; Denominator: 971585; Percentage: 1.58%. Numerator: 15336; Denominator: 971585; Percentage: 1.58%. Numerator: 15336; Denominator: 971585; Percentage: 1.58%. Numerator: 4061; Denominator: 1036041; Percentage: 0.39%. Numerator: 4061; Denominator: 1036041; Percentage: 0.39%. Numerator: 4061; Denominator: 1036041; Percentage: 0.39%. Numerator: 10009; Denominator: 1036041; Percentage: 0.97%. Numerator: 10009; Denominator: 1036041; Percentage: 0.97%. Numerator: 10009; Denominator: 1036041; Percentage: 0.97%. Numerator: 12797; Denominator: 1036041; Percentage: 1.24%. Numerator: 12797; Denominator: 1036041; Percentage: 1.24%. Numerator: 12797; Denominator: 1036041; Percentage: 1.24%. Numerator: 570; Denominator: 6619; Percentage: 8.61%. Numerator: 570; Denominator: 6619; Percentage: 8.61%. Numerator: 570; Denominator: 6619; Percentage: 8.61%. Numerator: 5565; Denominator: 1036041; Percentage: 0.54%. Numerator: 5565; Denominator: 1036041; Percentage: 0.54%. Numerator: 5565; Denominator: 1036041; Percentage: 0.54%. Numerator: 10505; Denominator: 1036041; Percentage: 1.01%. Numerator: 10505; Denominator: 1036041; Percentage: 1.01%. Numerator: 10505; Denominator: 1036041; Percentage: 1.01%.

Numerator: 6972.5; Denominator: 427761; Percentage: 1.63%. Numerator: 5249; Denominator: 443535; Percentage: 1.2%.

Numerator: 13945; Denominator: 855522; Percentage: 1.6%. Numerator: 9474; Denominator: 875943; Percentage: 1.1%.

Numerator: 6972.5; Denominator: 427761; Percentage: 1.63%. Numerator: 4225; Denominator: 432408; Percentage: 1%.

Numerator: 5318.86; Denominator: 371948; Percentage: 1.43%. Numerator: 4110; Denominator: 435601; Percentage: 0.9%. Numerator: 173; Denominator: 26047; Percentage: 0.66%. Numerator: 3937; Denominator: 409554; Percentage: 0.96%. Numerator: 765; Denominator: 275317; Percentage: 0.28%. Numerator: 1443; Denominator: 87339; Percentage: 1.65%. Numerator: 994. Numerator: 116; Denominator: 4203; Percentage: 2.76%. Numerator: 1385; Denominator: 73630; Percentage: 1.88%. Numerator: 2725; Denominator: 361971; Percentage: 0.75%.

Numerator: 10637.8; Denominator: 743896; Percentage: 1.4%. Numerator: 7934; Denominator: 874248; Percentage: 0.9%.

Numerator: 5318.86; Denominator: 371948; Percentage: 1.43%. Numerator: 3824; Denominator: 438647; Percentage: 0.9%. Numerator: 188; Denominator: 438647; Percentage: 0.04%. Numerator: 3636; Denominator: 438647; Percentage: 0.83%. Numerator: 505; Denominator: 281550; Percentage: 0.18%. Numerator: 1601; Denominator: 89225; Percentage: 1.79%. Numerator: 1168; Denominator: 18670; Percentage: 6.26%. Numerator: 60; Denominator: 4221; Percentage: 1.42%. Numerator: 1317; Denominator: 438647; Percentage: 0.3%. Numerator: 2507; Denominator: 438647; Percentage: 0.57%.

Numerator: 5686.4; Denominator: 386830; Percentage: 1.47%. Numerator: 5575; Denominator: 428303; Percentage: 1.3%. Numerator: 454; Denominator: 25586; Percentage: 1.77%. Numerator: 5121; Denominator: 402717; Percentage: 1.27%. Numerator: 357; Denominator: 428303; Percentage: 0.08%. Numerator: 479; Denominator: 428303; Percentage: 0.11%. Numerator: 50; Denominator: 428303; Percentage: 0.01%. Numerator: 18; Denominator: 3255; Percentage: 0.55%. Numerator: 1797; Denominator: 428303; Percentage: 0.42%. Numerator: 3778; Denominator: 428303; Percentage: 0.88%.

Numerator: 11372.8; Denominator: 773660; Percentage: 1.5%. Numerator: 8214; Denominator: 836609; Percentage: 1%.

Numerator: 5686.4; Denominator: 386830; Percentage: 1.47%. Numerator: 2639; Denominator: 408306; Percentage: 0.6%.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 6568; Denominator: 10755.

Numerator: 4237; Denominator: 11299. Numerator: 3133; Denominator: 11299.

Numerator: 8474; Denominator: 11299. Numerator: 8221; Denominator: 11299.

Numerator: 4628; Denominator: 11570. Numerator: 2964; Denominator: 11570.

Numerator: 9256; Denominator: 11570. Numerator: 7878; Denominator: 11570.

Numerator: 5035; Denominator: 11847. Numerator: 4509; Denominator: 11847.

Numerator: 10070; Denominator: 11847. Numerator: 11110; Denominator: 11847.

<narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 10; Denominator: 864.

Numerator: 91; Denominator: 906. Numerator: 1216; Denominator: 906.

Numerator: 45.5; Denominator: 906. Numerator: 482; Denominator: 906.

Numerator: 91; Denominator: 906. Numerator: 1216; Denominator: 906.

Numerator: 146; Denominator: 928. Numerator: 2648; Denominator: 928.

Numerator: 73; Denominator: 928. Numerator: 1354; Denominator: 928.

Numerator: 146; Denominator: 928. Numerator: 2648; Denominator: 928.

Numerator: 214; Denominator: 950. Numerator: 2362; Denominator: 950.

Numerator: 107; Denominator: 950. Numerator: 1053; Denominator: 950.

Numerator: 214; Denominator: 950. Numerator: 2362; Denominator: 950.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 37590; Denominator: 59354; Percentage: 63.33%. Numerator: 37590.

Numerator: 22406; Denominator: 62238; Percentage: 36%. Numerator: 16920; Denominator: 62238; Percentage: 27.2%.

Numerator: 44812; Denominator: 62238; Percentage: 72%. Numerator: 33122; Denominator: 62238; Percentage: 53.2%.

Numerator: 25174; Denominator: 63732; Percentage: 39.5%. Numerator: 16631; Denominator: 63732; Percentage: 26.1%.

Numerator: 50348; Denominator: 63732; Percentage: 79%. Numerator: 38010; Denominator: 63732; Percentage: 59.6%.

Numerator: 56125; Denominator: 65262; Percentage: 86%. Numerator: 48010; Denominator: 65262; Percentage: 73.6%.

Numerator: 28063; Denominator: 65262; Percentage: 43%. Numerator: 24279; Denominator: 65262; Percentage: 37.2%.

Numerator: 56125; Denominator: 65262; Percentage: 86%. Numerator: 48010; Denominator: 65262; Percentage: 73.6%.

<narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1439; Denominator: 5316; Percentage: 27.07%. Numerator: 225. Numerator: 225. Numerator: 225. Numerator: 225. Numerator: 225. Numerator: 1214. Numerator: 1214. Numerator: 1214. Numerator: 1214. Numerator: 1214.

Numerator: 4078; Denominator: 4941.5; Percentage: 82.5%. Numerator: 2175; Denominator: 4941; Percentage: 44%.

Numerator: 2039; Denominator: 2470.5; Percentage: 82.53%. Numerator: 1035; Denominator: 2470; Percentage: 41.9%.

Numerator: 2039; Denominator: 2471; Percentage: 82.53%. Numerator: 1140; Denominator: 2471; Percentage: 46.1%. Numerator: 81; Denominator: 1140; Percentage: 7.11%. Numerator: 1059; Denominator: 1140; Percentage: 92.89%.

Numerator: 4202; Denominator: 4706; Percentage: 89.3%. Numerator: 2300; Denominator: 4706; Percentage: 48.9%.

Numerator: 2101; Denominator: 2353; Percentage: 89.27%. Numerator: 1181; Denominator: 2353; Percentage: 50.2%. Numerator: 72; Denominator: 1181; Percentage: 6.1%. Numerator: 1109; Denominator: 1181; Percentage: 93.9%.

Numerator: 2101; Denominator: 2353; Percentage: 89.27%. Numerator: 1119; Denominator: 2353; Percentage: 47.6%. Numerator: 87; Denominator: 1119; Percentage: 7.77%. Numerator: 1032; Denominator: 1119; Percentage: 92.23%.

Numerator: 4244; Denominator: 4464; Percentage: 95.1%. Numerator: 1776; Denominator: 4464; Percentage: 39.8%.

Numerator: 2122; Denominator: 2232; Percentage: 95.05%. Numerator: 984; Denominator: 2232; Percentage: 44.1%. Numerator: 10; Denominator: 984; Percentage: 1.02%. Numerator: 974; Denominator: 984; Percentage: 98.98%.

Numerator: 2122; Denominator: 2232; Percentage: 95.05%. Numerator: 792; Denominator: 2232; Percentage: 35.5%. Numerator: 0; Denominator: 792; Percentage: 0%. Numerator: 788; Denominator: 792; Percentage: 99.49%.

<narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 3721; Denominator: 5316.

Numerator: 4078; Denominator: 4941. Numerator: 2534; Denominator: 4941.

Numerator: 2039; Denominator: 4941. Numerator: 1369; Denominator: 4941.

Numerator: 2039; Denominator: 4941. Numerator: 1165; Denominator: 4941.

Numerator: 4202; Denominator: 4706. Numerator: 3218; Denominator: 4706.

Numerator: 2101; Denominator: 4706. Numerator: 1199; Denominator: 4706.

Numerator: 2101; Denominator: 4706. Numerator: 2019; Denominator: 4706.

Numerator: 2121.5; Denominator: 4464. Numerator: 1036; Denominator: 4464.

Numerator: 4243; Denominator: 4464. Numerator: 2265; Denominator: 4464.

Numerator: 2121.5; Denominator: 4464. Numerator: 1229; Denominator: 4464.

<narrative>Percentage of pregnant women who know their HIV status</narrative> Module: PMTCT. <narrative>Percentage of pregnant women who know their HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 425196; Denominator: 549577; Percentage: 77.37%. Numerator: 4061. Numerator: 4061. Numerator: 4061. Numerator: 4061. Numerator: 4061. Numerator: 421135. Numerator: 421135. Numerator: 421135. Numerator: 421135. Numerator: 421135.

Numerator: 462966; Denominator: 573311; Percentage: 80.8%. Numerator: 572089; Denominator: 573311; Percentage: 99.8%.

Numerator: 231483; Denominator: 573311; Percentage: 40.38%. Numerator: 277243; Denominator: 573311; Percentage: 48.4%.

Numerator: 231483; Denominator: 573311; Percentage: 40.38%. Numerator: 294846; Denominator: 573311; Percentage: 51.4%. Numerator: 1203; Denominator: 294846; Percentage: 0.41%. Numerator: 293643; Denominator: 294846; Percentage: 99.59%.

Numerator: 500344; Denominator: 585187; Percentage: 85.5%. Numerator: 603478; Denominator: 585187; Percentage: 103.1%.

Numerator: 250172; Denominator: 585187; Percentage: 42.75%. Numerator: 306656; Denominator: 585187; Percentage: 52.4%. Numerator: 1397; Denominator: 306656; Percentage: 0.46%. Numerator: 305259; Denominator: 306656; Percentage: 99.54%.

Numerator: 250172; Denominator: 585187; Percentage: 42.75%. Numerator: 296822; Denominator: 585187; Percentage: 50.7%. Numerator: 1248; Denominator: 296822; Percentage: 0.42%. Numerator: 295574; Denominator: 296822; Percentage: 99.58%.

Numerator: 269096; Denominator: 596335; Percentage: 45.12%. Numerator: 280202; Denominator: 596335; Percentage: 47%. Numerator: 4448; Denominator: 280202; Percentage: 1.59%. Numerator: 275754; Denominator: 280202; Percentage: 98.41%.

Numerator: 538192; Denominator: 596335; Percentage: 90.2%. Numerator: 553432; Denominator: 596335; Percentage: 92.8%.

Numerator: 269096; Denominator: 596335; Percentage: 45.12%. Numerator: 273230; Denominator: 596335; Percentage: 45.8%. Numerator: 272286; Denominator: 273230; Percentage: 99.65%. Numerator: 944; Denominator: 273230; Percentage: 0.35%.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 14831; Denominator: 10755.

Numerator: 5519.5; Denominator: 11299. Numerator: 6186; Denominator: 11299.

Numerator: 11039; Denominator: 11299. Numerator: 14517; Denominator: 11299.

Numerator: 11304; Denominator: 11570. Numerator: 13996; Denominator: 11570.

Numerator: 5652; Denominator: 11570. Numerator: 6164; Denominator: 11570.

Numerator: 11304; Denominator: 11570. Numerator: 13996; Denominator: 11570.

Numerator: 11575; Denominator: 11847. Numerator: 14288; Denominator: 11847.

Numerator: 5787.5; Denominator: 11847. Numerator: 6705; Denominator: 11847.

Numerator: 11575; Denominator: 11847. Numerator: 14288; Denominator: 11847.

<narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 208; Denominator: 864.

Numerator: 181; Denominator: 906. Numerator: 2105; Denominator: 906.

Numerator: 362; Denominator: 906. Numerator: 3924; Denominator: 906.

Numerator: 209; Denominator: 928. Numerator: 2353; Denominator: 928.

Numerator: 417; Denominator: 928. Numerator: 6022; Denominator: 928.

Numerator: 237.5; Denominator: 950. Numerator: 3758; Denominator: 950.

Numerator: 475; Denominator: 950. Numerator: 8736; Denominator: 950.

<narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 49989; Denominator: 59354; Percentage: 84.22%. Numerator: 49989.

Numerator: 27466; Denominator: 62238; Percentage: 44.13%. Numerator: 27294; Denominator: 62238; Percentage: 43.8%.

Numerator: 54932; Denominator: 62238; Percentage: 88.3%. Numerator: 53337; Denominator: 62238; Percentage: 85.7%.

Numerator: 54932; Denominator: 62238; Percentage: 88.26%. Numerator: 53337; Denominator: 62238; Percentage: 85.7%.

Numerator: 56887; Denominator: 63732; Percentage: 89.3%. Numerator: 58402; Denominator: 63732; Percentage: 91.6%.

Numerator: 28443.5; Denominator: 63732; Percentage: 44.63%. Numerator: 26461; Denominator: 63732; Percentage: 41.5%.

Numerator: 56887; Denominator: 63732; Percentage: 89.26%. Numerator: 58402; Denominator: 63732; Percentage: 91.6%.

Numerator: 29453; Denominator: 65262; Percentage: 45.13%. Numerator: 33292; Denominator: 65262; Percentage: 51%.

Numerator: 58905; Denominator: 65262; Percentage: 90.3%. Numerator: 70689; Denominator: 65262; Percentage: 108.3%.

Numerator: 58905; Denominator: 65262; Percentage: 90.26%. Numerator: 70689; Denominator: 65262; Percentage: 108.3%.

<narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 162; Denominator: 166.

Numerator: 187; Denominator: 191.

Numerator: 187; Denominator: 191. Numerator: 186; Denominator: 199.

Numerator: 212; Denominator: 216. Numerator: 199; Denominator: 221.

Numerator: 212; Denominator: 216. Numerator: 200; Denominator: 207.

Numerator: 212; Denominator: 216. Numerator: 199; Denominator: 221.

Numerator: 212; Denominator: 216. Numerator: 209; Denominator: 225.

Numerator: 212; Denominator: 216. Numerator: 197; Denominator: 221.

Numerator: 212; Denominator: 216. Numerator: 209; Denominator: 225.

<narrative>TCP-Other 1: Number of children below 5 living with HIV and/or in contact with TB patients whi started preventive treatment</narrative> Module: TB care and prevention. <narrative>TCP-Other 1: Number of children below 5 living with HIV and/or in contact with TB patients whi started preventive treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.

<narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6755; Denominator: 7202. Numerator: 2357; Denominator: 2525. Numerator: 2357; Denominator: 2525. Numerator: 2357; Denominator: 2525. Numerator: 2357; Denominator: 2525. Numerator: 2357; Denominator: 2525. Numerator: 4398; Denominator: 4677. Numerator: 4398; Denominator: 4677. Numerator: 4398; Denominator: 4677. Numerator: 4398; Denominator: 4677. Numerator: 4398; Denominator: 4677. Numerator: 639; Denominator: 761. Numerator: 639; Denominator: 761. Numerator: 639; Denominator: 761. Numerator: 639; Denominator: 761. Numerator: 639; Denominator: 761.

Numerator: 3450; Denominator: 3646.

Numerator: 6840; Denominator: 7215.

Numerator: 3390; Denominator: 3569. Numerator: 1077; Denominator: 1132. Numerator: 2313; Denominator: 2437. Numerator: 228; Denominator: 253.

Numerator: 6500; Denominator: 6874.

Numerator: 3419; Denominator: 3617. Numerator: 1100; Denominator: 1155. Numerator: 2319; Denominator: 2462. Numerator: 185; Denominator: 219.

Numerator: 3081; Denominator: 3257. Numerator: 991; Denominator: 1059. Numerator: 2090; Denominator: 2198. Numerator: 162; Denominator: 178.

Numerator: 3330; Denominator: 3550. Numerator: 1109; Denominator: 1186. Numerator: 2221; Denominator: 2364. Numerator: 220; Denominator: 259.

Numerator: 6646; Denominator: 7101.

Numerator: 3316; Denominator: 3551. Numerator: 1073; Denominator: 1156. Numerator: 2243; Denominator: 2395. Numerator: 223; Denominator: 261.

<narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 567; Denominator: 570.

Numerator: 892; Denominator: 892. Numerator: 386; Denominator: 386.

Numerator: 446; Denominator: 446. Numerator: 210; Denominator: 210.

Numerator: 446; Denominator: 446. Numerator: 176; Denominator: 176.

Numerator: 490; Denominator: 490. Numerator: 218; Denominator: 218.

Numerator: 980; Denominator: 980. Numerator: 422; Denominator: 437.

Numerator: 490; Denominator: 490. Numerator: 204; Denominator: 219.

Numerator: 1078; Denominator: 1078. Numerator: 427; Denominator: 436.

Numerator: 539; Denominator: 539. Numerator: 237; Denominator: 240.

Numerator: 539; Denominator: 539. Numerator: 190; Denominator: 196.

<narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 8134; Denominator: 19333.

Numerator: 3822.77; Denominator: 5097.03. Numerator: 8486; Denominator: 10671.

<narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 37. Numerator: 37. Numerator: 37. Numerator: 37. Denominator: 181; Percentage: 0%. Denominator: 181; Percentage: 0%. Denominator: 181; Percentage: 0%. Denominator: 181; Percentage: 0%. Numerator: 1524. Numerator: 1524. Numerator: 1524. Numerator: 1524. Numerator: 2913. Numerator: 2913. Numerator: 2913. Numerator: 2913.

Numerator: 39; Denominator: 3401; Percentage: 1.15%. Numerator: 3262; Denominator: 3401; Percentage: 95.91%. Numerator: 1165; Denominator: 3401; Percentage: 34.25%. Numerator: 2236; Denominator: 3401; Percentage: 65.75%.

Numerator: 64; Denominator: 2871; Percentage: 2.23%. Numerator: 2732; Denominator: 2871; Percentage: 95.16%. Numerator: 1036; Denominator: 2871; Percentage: 36.08%. Numerator: 1835; Denominator: 2871; Percentage: 63.92%.

Numerator: 23; Denominator: 2002; Percentage: 1.15%. Numerator: 1951; Denominator: 2002; Percentage: 97.45%. Numerator: 686; Denominator: 2002; Percentage: 34.27%. Numerator: 1316; Denominator: 2002; Percentage: 65.73%.

Numerator: 2573; Denominator: 2657; Percentage: 96.84%. Numerator: 22; Denominator: 2657; Percentage: 0.83%. Numerator: 1645; Denominator: 2657; Percentage: 61.91%. Numerator: 1012; Denominator: 2657; Percentage: 38.09%.

<narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6619; Denominator: 6828.

Numerator: 8100; Denominator: 8100. Numerator: 6845; Denominator: 6874.

Numerator: 4050; Denominator: 4050. Numerator: 3603; Denominator: 3617.

Numerator: 4050; Denominator: 4050. Numerator: 3242; Denominator: 3257.

Numerator: 8910; Denominator: 8910. Numerator: 7558; Denominator: 7757.

Numerator: 4455; Denominator: 4455. Numerator: 3709; Denominator: 3764.

Numerator: 4455; Denominator: 4455. Numerator: 3849; Denominator: 3993.

Numerator: 9800; Denominator: 9800. Numerator: 7837; Denominator: 7981.

Numerator: 4900; Denominator: 4900. Numerator: 4167; Denominator: 4240.

Numerator: 4900; Denominator: 4900. Numerator: 3670; Denominator: 3741.

<narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 66619; Denominator: 76389. Numerator: 4217; Denominator: 66831. Numerator: 4217; Denominator: 66831. Numerator: 4217; Denominator: 66831. Numerator: 4217; Denominator: 66831. Numerator: 4217; Denominator: 66831.

Numerator: 72053.64; Denominator: 76145.96. Numerator: 70606; Denominator: 76146.

Numerator: 72053.6; Denominator: 76146. Numerator: 70990; Denominator: 76146.

Numerator: 72053.64; Denominator: 76145.96. Numerator: 70990; Denominator: 76146. Numerator: 3766; Denominator: 70990.

Numerator: 75548; Denominator: 79953.26. Numerator: 72319; Denominator: 79953. Numerator: 4127; Denominator: 72319.

Numerator: 75548; Denominator: 79953.3. Numerator: 72896; Denominator: 79953.

Numerator: 75548; Denominator: 79953.26. Numerator: 72896; Denominator: 79953. Numerator: 3184; Denominator: 72896.

Numerator: 75548; Denominator: 79953.3. Numerator: 74083; Denominator: 79953.

Numerator: 75548; Denominator: 79953.26. Numerator: 70846; Denominator: 79953. Numerator: 4398; Denominator: 70846.

Numerator: 75548; Denominator: 79953.26. Numerator: 74083; Denominator: 79953. Numerator: 47864; Denominator: 74083.

<narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 3318; Denominator: 9575. Numerator: 1723; Denominator: 3383. Numerator: 1723; Denominator: 3383. Numerator: 1723; Denominator: 3383. Numerator: 1723; Denominator: 3383. Numerator: 1723; Denominator: 3383. Numerator: 220; Denominator: 3383. Numerator: 220; Denominator: 3383. Numerator: 220; Denominator: 3383. Numerator: 220; Denominator: 3383. Numerator: 220; Denominator: 3383. Numerator: 1595; Denominator: 3383. Numerator: 1595; Denominator: 3383. Numerator: 1595; Denominator: 3383. Numerator: 1595; Denominator: 3383. Numerator: 1595; Denominator: 3383.

Numerator: 4092; Denominator: 7956. Numerator: 2865; Denominator: 7956.

Numerator: 4092; Denominator: 7956. Numerator: 2808; Denominator: 7956.

Numerator: 4092; Denominator: 7956. Numerator: 2808; Denominator: 7956. Numerator: 1422; Denominator: 2808. Numerator: 158; Denominator: 2808. Numerator: 1386; Denominator: 2808.

Numerator: 4405; Denominator: 7270. Numerator: 2716; Denominator: 7270. Numerator: 1360; Denominator: 2716. Numerator: 187; Denominator: 2716. Numerator: 1356; Denominator: 2716.

Numerator: 4405; Denominator: 7270. Numerator: 2707; Denominator: 7270.

Numerator: 4405; Denominator: 7270. Numerator: 2707; Denominator: 7270. Numerator: 1348; Denominator: 2707. Numerator: 158; Denominator: 2707. Numerator: 1359; Denominator: 2707.

Numerator: 4405; Denominator: 7270. Numerator: 2437; Denominator: 7270. Numerator: 1210; Denominator: 2437. Numerator: 150; Denominator: 2437. Numerator: 1227; Denominator: 2437.

Numerator: 4405; Denominator: 7270. Numerator: 2405; Denominator: 7270.

Numerator: 4405; Denominator: 7270. Numerator: 2405; Denominator: 7270. Numerator: 1237; Denominator: 2405. Numerator: 1168; Denominator: 2405. Numerator: 176; Denominator: 2405.